
DenialHelp
Home health denied? We cite 42 CFR §484, Medicare Benefit Policy Manual Ch 7, and Jimmo v Sebelius.
AI-drafted appeals for skilled home nursing, home infusion (IVIG, biologic, OPAT, TPN), home PT/OT/SLP, home health aide, and Hospital-at-Home denials — citing 42 CFR §484 Home Health CoP, Medicare PDGM, CMS Manual Ch 7 homebound criteria, Jimmo v Sebelius 2013, AHCAH waiver, NAHC, and INS Standards.
Four steps. Under 10 minutes.
Upload your denial — and any clinical records you have
Take a photo, scan, or upload PDFs of the denial letter. Adding labs, prior PA letters, or visit notes makes the appeal stronger — but the denial alone is enough to start.
Confirm a few facts
We pre-fill what we extracted. You confirm or edit. Takes 2 minutes.
We draft your appeal
Insurer-specific clinical citations, medical-necessity arguments, ready in minutes.
Your doctor signs and files
We email the letter to you. Your doctor reviews, signs, and submits.
Ready to fight your denial?
We charge once, only when we deliver a letter your doctor can sign. If your denial can't be appealed, you don't pay.
Why home healthcare denials follow a different playbook
Home healthcare lives at the intersection of three coverage frameworks that trip up patients, families, and ordering physicians: federal home health Conditions of Participation (42 CFR §484), the Medicare Benefit Policy Manual Chapter 7 (homebound + skilled-service rules), and the Jimmo v Sebelius settlement that ended the "improvement standard." Each one matters in nearly every appeal, and most denials hinge on getting one of them wrong.
The good news: the rules are written down. Once you know which CFR section, which Manual chapter, and which guideline applies, drafting the appeal is mechanical.
This guide walks through the most common home-healthcare denial categories — skilled nursing, home infusion, home PT/OT/SLP, home health aide, Hospital-at-Home, and pediatric home health — and the specific evidence each one requires.
The denial categories you'll actually see
Five reasons account for the vast majority of home-healthcare denials:
1. "Not homebound." The most common Medicare-style denial.
2. "Service is custodial, not skilled." The classic skilled-vs-unskilled dispute.
3. "Plateaued / no improvement." Defeated by Jimmo v Sebelius.
4. "Home infusion not necessary — use the infusion center." Common for IVIG, biologics, OPAT, TPN.
5. "F2F encounter or plan of care missing." Procedural / documentation denials.
Each one has a specific federal regulatory or guideline-based counter.
Homebound: the rule is narrower than insurers pretend
The CMS Medicare Benefit Policy Manual Chapter 7 §30.1.1 defines homebound as:
> The patient leaves home only with considerable and taxing effort, and only for short duration, primarily for medical care.
Key clarifications insurers often miss:
- Homebound does not mean bedbound. A patient can leave home, including for medical appointments, hair appointments, religious services, family events, walks, or drives — without forfeiting homebound status — as long as the absences are infrequent, of short duration, and the patient leaves only with considerable and taxing effort.
- Assistive devices count. Walker, cane, wheelchair, motorized scooter, supplemental oxygen — these support homebound status.
- Taxing effort matters. A patient who needs hours of recovery after an outing meets the standard.
When an insurer denies with "patient is not homebound," the appeal cites Manual Ch 7 §30.1.1 verbatim, then documents:
- Specific assistive device(s) used.
- Pattern of absences (frequency, duration, purpose).
- Evidence of taxing effort (assistance required, post-outing fatigue, recovery time).
- Primarily-medical absence pattern.
Patients who attend dialysis three times per week are still homebound. Patients who go to chemo / infusion / radiation are still homebound. The Medicare framework explicitly anticipates these absences.
Skilled service: defined by complexity, not by who happens to provide it
CMS Pub 100-02 Ch 7 §40 defines a skilled service as one that — because of the complexity of the service or the patient's condition — can only be safely or effectively provided by skilled personnel (RN, LPN, PT, OT, SLP).
Examples that are clearly skilled:
- IV infusion administration (IVIG, biologics, antibiotics, TPN).
- Wound care that involves measurement, staging, packing, debridement, VAC.
- Complex medication titration (insulin pump troubleshooting, anticoagulation adjustment).
- Catheter / ostomy / PEG / NG management.
- Tracheostomy care and suctioning.
- Patient / caregiver education on a new complex regimen.
- Skilled assessment of a clinically unstable patient.
- Gait training with progression after stroke or fracture.
- Swallow management post-stroke or post-surgery.
Examples that are unskilled (HHA, not skilled nursing):
- Bathing, dressing, basic feeding assistance.
- Routine ambulation without therapeutic skill.
- Basic toileting.
The line is not about which discipline performs the task — it's about whether a non-skilled caregiver could safely perform it. The successful appeal documents the specific skilled task and the reason an unskilled caregiver cannot perform it.
Intermittent or part-time
Medicare home health coverage requires service to be intermittent (recurring need on a part-time basis) rather than continuous. The threshold is generally:
- Skilled nursing: less than 8 hours per day, less than 28 hours per week (with some flexibility up to 35 hours under specific circumstances).
- Home health aide: similar limits, generally part-time and intermittent.
For continuous skilled needs (e.g., 24-hour vent management for a complex pediatric patient), Medicare home health is generally not the right benefit; instead, look at Medicaid private-duty nursing (PDN) under EPSDT for children, or specific commercial plan benefits for adults.
Jimmo v Sebelius: the end of the "no improvement" denial
The 2013 Jimmo v Sebelius settlement and the subsequent CMS Pub 100-02 Ch 7, 8, and 15 revisions are unambiguous:
> Coverage of skilled nursing and skilled therapy services does not turn on the presence or absence of an individual's potential for improvement, but rather on the beneficiary's need for skilled care.
Maintenance therapy is covered. Decline-prevention is covered. A patient who has plateaued but who needs ongoing skilled service to maintain function is covered.
When an insurer denies with "patient has plateaued" or "no further improvement expected," the appeal cites Jimmo v Sebelius 2013, the CMS Manual revisions by chapter and section, and documents the specific skilled service required to maintain function or prevent decline.
This is one of the highest-leverage citations in all of home healthcare appeals. Most medical directors know Jimmo exists, but many insurer auto-denials still cite "no improvement" — and reverse on first appeal when the citation is invoked.
The F2F encounter: 42 CFR §484 + Manual Ch 7
Medicare home health requires a face-to-face encounter by the certifying physician (or NP/PA) within 90 days prior to or 30 days after the start of care. The F2F:
- Must be a clinical encounter (in person; telehealth permitted under current CMS rules — verify the current authorization status).
- Must be documented in the medical record.
- Is required at the start of each home-health episode (not just initial start-of-care).
A missing F2F is a procedural denial, not a substantive one. The fix is to complete and document the F2F (with appropriate timing) and resubmit.
The plan of care (CMS-485)
The home-health plan of care (CMS-485 or equivalent) must include:
- Patient diagnoses with ICD-10.
- Specific services ordered (skilled nursing, PT, OT, SLP, HHA).
- Frequency and duration.
- Goals.
- Safety measures.
- Recertification date (every 60 days for traditional Medicare; per plan rules for MA / commercial).
- Ordering provider signature and NPI.
A complete CMS-485 disposes of "documentation insufficient" denials.
Home infusion: the center-vs-home debate
Insurer denials of home infusion (IVIG, biologics, OPAT, TPN) usually take the form: "the infusion can be administered safely at the infusion center; home infusion is not medically necessary." The successful counter documents:
Drug-specific home administration safety. INS (Infusion Nurses Society) Standards of Practice — updated approximately every 5 years — establish the framework for safe home IV administration. For IVIG, AAN/AANEM IVIG efficacy and safety data support home administration in stable patients. For OPAT, IDSA OPAT Guidelines (Norris CID 2018) explicitly endorse home administration with appropriate access, monitoring, and ID oversight. For TPN, ASPEN Clinical Guidelines establish home parenteral nutrition standards.
Patient-specific barriers to center. Document the specific reasons home is preferred:
- Transportation difficulty (no driver, distance >30 min, traffic, weather).
- Work or school conflict.
- Immune-compromise (transplant, chemotherapy, neutropenia) making the center high-risk.
- Mobility (wheelchair-bound, complex gait).
- Caregiving (patient is primary caregiver for another family member).
- Distance from any infusion center.
Prior tolerance. Document the number of prior cycles in the center without reactions, supporting that the patient is a stable home-infusion candidate.
Cost-effectiveness. Home infusion is usually cheaper than center infusion when professional fees, facility fees, and travel costs are accounted for. Most plans actually save money on home infusion when the patient is a candidate.
OPAT: the IDSA framework
For home OPAT (Outpatient Parenteral Antimicrobial Therapy), the IDSA OPAT Guidelines (Norris CID 2018) are decisive. Key points for the appeal:
- Drug suitability. Cefazolin, ceftriaxone, ertapenem, vancomycin, daptomycin, ampicillin, oxacillin, piperacillin-tazobactam (with appropriate stability) — all routinely administered at home.
- IV access. PICC line, midline, or tunneled central venous catheter as appropriate for duration.
- Monitoring. Weekly MD F2F or telehealth, ID consultation, lab monitoring (CBC weekly, BMP, vancomycin troughs as indicated, drug-specific monitoring).
- First-dose observation. For drugs with reaction risk, observe first dose in clinic / hospital before transitioning home.
The Tice CID 2003 cost-effectiveness data is foundational for OPAT coverage. Cite it.
Home PT, OT, SLP: skilled-vs-maintenance-vs-custodial
Home PT/OT/SLP denials usually fall into three categories:
1. "Plateaued — discharge from PT." Defeated by Jimmo (maintenance therapy is covered).
2. "Custodial — does not require skilled PT." Defeated by documenting the specific skilled task (gait training with progression, neuromuscular re-education, fall-prevention strategies, complex transfer training, post-stroke NDT, swallow management for SLP) that requires therapy-level skill.
3. "Frequency excessive." Defeated by functional measures and POC justification.
Quantitative functional measures matter:
- BBS (Berg Balance Scale) for fall risk and balance.
- 10MWT (10-meter walk test) for gait speed.
- AM-PAC (Activity Measure for Post-Acute Care) for daily activity.
- FIM motor scores (still used by many payers).
- mJOA / Nurick for cervical myelopathy recovery.
- DASH / MHQ for upper extremity / hand.
- NDT (Neurodevelopmental Treatment) progression notes for stroke / TBI recovery.
A trajectory — admission, current, goal — matters more than a single point.
Hospital-at-Home: the AHCAH waiver
The Acute Hospital Care at Home (AHCAH) waiver was first authorized November 25, 2020 under the COVID-19 PHE. The Consolidated Appropriations Act of 2023 extended it through December 31, 2024. FY2025 status depends on the most recent budget action — verify current authorization at the time of appeal.
AHCAH eligibility:
- AHCAH-waiver-enrolled hospital. Not all hospitals are enrolled.
- Selected DRGs. Common qualifying DRGs include community-acquired pneumonia, COPD exacerbation, CHF exacerbation, UTI / pyelonephritis, cellulitis, and selected post-surgical recoveries. Each AHCAH program has its own list.
- Clinical stability that allows home-level acute care.
- Daily physician F2F (telehealth permitted).
- 2x/day RN F2F.
- Remote monitoring kit with continuous vital-sign capture and emergency response capability.
- Adequate social environment at home (caregiver, accessibility, communication).
Outcome data supports AHCAH: Levine et al JAMA Internal Medicine 2020 and Annals of Internal Medicine 2020 (Mount Sinai and Brigham series) showed comparable clinical outcomes, reduced 30-day readmission, lower cost, and patient preference for the home-based model.
When an insurer denies AHCAH, the appeal must verify the program is AHCAH-waiver-enrolled, document the DRG eligibility, document the clinical monitoring infrastructure, and cite the outcome literature.
Pediatric home health: EPSDT and PDN
Pediatric home healthcare for medically complex children is governed by Early Periodic Screening Diagnostic and Treatment (EPSDT) under Medicaid. EPSDT mandates "necessary" services for children, which courts and CMS have interpreted broadly. Private-duty nursing (PDN) — continuous nursing care at home for vent-dependent, trach-dependent, TPN-dependent, or otherwise medically complex children — is covered under EPSDT when justified by complexity.
When PDN or pediatric home health is denied as "excessive":
- Cite EPSDT and CMS State Medicaid Director guidance.
- Document pediatric medical complexity (vent, trach, TPN, complex meds, neurodevelopmental needs, technology dependence).
- Document the family-care plan with backup nursing.
- Distinguish school-day PDN from full-time PDN as appropriate.
- Cite AAP, Title V, and Family Voices position statements on medically complex children.
The peer-to-peer call: prepare it before you write
For home-healthcare denials, the peer-to-peer reviewer should be a clinician familiar with home health regulation — ideally same-specialty (the ordering physician's specialty) or geriatric medicine / hospice and palliative medicine for non-pediatric cases, or pediatric medicine for pediatric cases. Demand same-specialty review.
The peer-to-peer call should bring:
1. Manual Ch 7 §30.1.1 verbatim (homebound).
2. CMS Pub 100-02 Ch 7 §40 verbatim (skilled service).
3. Jimmo v Sebelius citation (no improvement requirement).
4. The specific skilled task and reason an unskilled caregiver cannot perform it.
5. The F2F encounter and plan of care.
6. Drug / procedure-specific guideline (INS, IDSA OPAT, ASPEN, AHCAH).
Expedited / urgent appeals
Home-healthcare denials for active services should trigger expedited appeal. Most plans have a 24-72 hour expedited track when discontinuation of service would jeopardize the patient. Use it.
For Medicare Advantage, 42 CFR §422 Subpart M governs the appeal process, leading to Independent Review Entity (Maximus) review, then ALJ, Medicare Appeals Council, and judicial review.
For ERISA / commercial plans, ACA §2719 governs external review. Most states have additional protections through the state insurance department.
Letter structure and tone
A good home-healthcare appeal is 1.5 to 2 pages:
1. Header — member ID, claim #, service requested, ordering provider, dates, HCPCS / J-codes.
2. Diagnosis + ICD-10 + clinical context driving home-based care.
3. Homebound documentation (for Medicare-style policies) — assistive device, taxing effort, absence pattern.
4. Skilled service justification — specific task, frequency, reason unskilled caregiver cannot perform.
5. F2F encounter + plan of care — date, ordering clinician, content, recertification cadence.
6. For home infusion: drug + dose + IV access + monitoring + prior tolerance + INS/IDSA/ASPEN compliance.
7. For Hospital-at-Home: AHCAH-eligible DRG + waiver status + monitoring infrastructure.
8. For PT/OT/SLP: functional measures + Jimmo applicability if maintenance.
9. Address denial reason directly — quote insurer's policy + 42 CFR §484 + Manual Ch 7 + Jimmo + applicable specialty guideline.
10. Closing — request overturn within deadline, demand expedited review, demand peer-to-peer.
Tone is professional, firm, evidence-driven. The medical director responds to specific federal citations and clinical evidence, not adjectives.
What good looks like
A successful home-healthcare appeal:
- Quotes 42 CFR §484 + Medicare Manual Ch 7 §30.1.1 (homebound) + Pub 100-02 Ch 7 §40 (skilled service).
- Cites Jimmo v Sebelius 2013 + post-Jimmo Manual revisions for any "plateaued" denial.
- Cites CMS AHCAH waiver authorization for Hospital-at-Home cases.
- Cites INS Standards / IDSA OPAT / ASPEN for home-infusion cases.
- Cites EPSDT + CMS State Medicaid Director guidance for pediatric PDN.
- Documents specific skilled task and reason unskilled caregiver cannot perform.
- Includes F2F encounter date and complete CMS-485.
- Includes functional measures (BBS, 10MWT, AM-PAC, FIM) for PT/OT/SLP.
- Documents barriers to alternative care setting (infusion center, hospital).
- Demands expedited review and peer-to-peer.
- Stays within 2 pages.
Most denials reverse on first appeal when these elements are present. The work is in the documentation. Once the chart contains the F2F, the CMS-485, the homebound evidence, and the skilled-task description, drafting the letter is mechanical.